TD Cowen upgraded shares of Stevanato Group (NYSE:STVN – Free Report) to a strong-buy rating in a research note released on Wednesday,Zacks.com reports.
A number of other equities research analysts also recently issued reports on STVN. Morgan Stanley decreased their price target on shares of Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, March 6th. KeyCorp reduced their target price on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, March 5th. Weiss Ratings restated a “sell (d+)” rating on shares of Stevanato Group in a research report on Monday, June 8th. Wolfe Research started coverage on shares of Stevanato Group in a report on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price target for the company. Finally, Citigroup dropped their price target on Stevanato Group from $32.00 to $26.00 and set a “buy” rating for the company in a research report on Thursday, March 5th. Two equities research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.
Read Our Latest Stock Report on Stevanato Group
Stevanato Group Stock Performance
Stevanato Group (NYSE:STVN – Get Free Report) last posted its earnings results on Friday, May 8th. The company reported €0.11 EPS for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). Stevanato Group had a net margin of 11.76% and a return on equity of 10.27%. The firm had revenue of €273.57 million for the quarter. During the same period in the prior year, the company earned $0.10 EPS. The business’s revenue was up 6.6% on a year-over-year basis. As a group, equities analysts anticipate that Stevanato Group will post 0.68 earnings per share for the current fiscal year.
Stevanato Group Cuts Dividend
The company also recently disclosed an annual dividend, which will be paid on Wednesday, July 29th. Shareholders of record on Thursday, June 11th will be given a dividend of $0.054 per share. The ex-dividend date is Thursday, June 11th. This represents a yield of 31.0%.
Institutional Investors Weigh In On Stevanato Group
Hedge funds and other institutional investors have recently made changes to their positions in the company. Fifth Third Bancorp boosted its stake in shares of Stevanato Group by 22.6% during the 1st quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock worth $58,000 after purchasing an additional 773 shares during the period. First Bank & Trust raised its position in Stevanato Group by 5.6% in the 4th quarter. First Bank & Trust now owns 17,109 shares of the company’s stock worth $344,000 after purchasing an additional 904 shares during the period. GW&K Investment Management LLC raised its position in Stevanato Group by 76.2% in the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after purchasing an additional 1,055 shares during the period. Pathstone Holdings LLC lifted its stake in Stevanato Group by 1.5% in the third quarter. Pathstone Holdings LLC now owns 71,178 shares of the company’s stock worth $1,833,000 after purchasing an additional 1,067 shares during the last quarter. Finally, Mariner LLC lifted its stake in Stevanato Group by 6.9% in the third quarter. Mariner LLC now owns 25,447 shares of the company’s stock worth $655,000 after purchasing an additional 1,638 shares during the last quarter.
About Stevanato Group
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
See Also
- Five stocks we like better than Stevanato Group
- How to Invest in the Biggest European Defense Surge in Decades
- The Netflix-Lionsgate Rumor Exposed a Bigger Shift in Media M&A
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
